Picard Reports Third Quarter 2025 Financial Results

– Completes IPO, Expands Patent Portfolio, and Strengthens Board Independence –

TUCSON, Ariz., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced financial results for the three and nine months ended September 30, 2025.

Read more at globenewswire.com